Skip to content
This site is intended for healthcare professionals only
This site is intended for healthcare professionals only
Home
Case studies
Expert interviews
eLearning
News
Expert challenge
Treatment options for
metastatic urothelial carcinoma:
Patient case studies
Case 2: First-line therapy for cisplatin-eligible patients followed by maintenance therapy
"
*
" indicates required fields
Evaluation form
Upon completion of this independent medical education activity, I am better able to:
*
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Discuss the standard of care in first line for patients with mUC who are eligible for cisplatin-based chemotherapy
Understand the clinical data supporting checkpoint inhibitor (ICI) maintenance therapy after first-line treatment in patients with mUC
How would you rate the overall quality of the case study activity?
*
1 = Poor, 10 = Excellent
1
2
3
4
5
6
7
8
9
10
This activity:
*
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
was based on relevant and current evidence
increased my knowledge of the topic
focused on competencies relevant to my practice
will help me improve patient care within my clinical practice
As a result of participating in this patient case study, will you make any measurable changes in your role?
*
Yes
Possibly, after additional training/information
No, but the content affirms my current daily practice
No, I am unable to implement the information
If YES, can you provide an example of how this event will influence your future practice?
*
If NO, what are the barriers that prevent you from making changes?
*
Did you feel there was any bias evident within the educational content?
*
No
Yes: Commercial (I felt there was undue prominence given to a specific product)
Yes: Professional (I felt there was inappropriate influence of a related organisation)
Yes: Personal (the personal interests of the author caused bias)
Yes (for other reasons)
If other, please give details
*
Are there any topics that you would like to see covered in future educational activities within this therapeutic area?
Would you recommend this activity to a colleague?
*
Yes
No
Would you like to hear about further oncology related educational programmes?
*
Yes
No
←
Previous Section
